• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM); AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM); AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED Back to Search Results
Model Number 1961
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/25/2021
Event Type  malfunction  
Event Description
A suspected product inquiry of (b)(6) during an ipo investigation.China supply chain checked and there was no record of the absorbable hemostat products.Additional information was requested.
 
Manufacturer Narrative
(b)(4).The following information was requested, but unavailable: - how was the product purchased? - is there an indication of how the product was distributed? - is there any indication of the source? - based on the packaging, is there any indication of which market the original genuine product may have come from? - was the device used on a patient? if so, was there any patient consequence? photo investigation summary: the packaging was observed to be according to the process specifications and the product was manufactured by ethicon, the diversion product is confirmed, since the ethicon product was not distributed by affiliate authorized.Investigation summary: the product was returned for evaluation.In a further investigation of the samples received, it was observed, that there was excessive carton damage and the artwork on the pouch and carton had added spacing mistakes.There were shading discrepancies on the carton when compared to approved artwork.The inside foil pouch appearance appears shinier than approved material appearance.In addition, it was noted time-stamp was identical for all packages of the same line.Based on the information currently available, counterfeit was identified during the investigation of the samples received.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM)
Type of Device
AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.
road 183, km. 8.3
san lorenzo 00754
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key15233575
MDR Text Key305344916
Report Number2210968-2022-06656
Device Sequence Number1
Product Code LMG
UDI-Device Identifier10705031003118
UDI-Public10705031003118
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
N12159
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1961
Device Catalogue Number1961
Device Lot NumberRRB1325
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/06/2022
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/08/2022
Initial Date FDA Received08/16/2022
Supplement Dates Manufacturer Received08/08/2022
Supplement Dates FDA Received08/17/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-